Tag Archives: clinical drug trials

Cognitive Testing in Clinical Drug Trials

Formal cognitive testing in pharmaceutical trials is relatively new.  Up until 2000, most drug trial designs did not include any form of baseline and end point cognitive testing, even for drugs that act directly on the central nervous system (CNS). A significant push towards standardized cognitive assessments in clinical drug trials occurred in 2005 when… Read More »